secwatch / observer
8-K filed April 5, 2023, 7:59 PM ET ticker BVS CIK 0001665988
leadership confidence high sentiment neutral materiality 0.70

Bioventus CEO Kenneth Reali departs; Anthony Bihl named interim CEO

Bioventus Inc.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Anthony P. Bihl III

Interim Chief Executive Officer
BVS · Bioventus Inc.
Effective
2023-04-05
Filed
April 5, 2023, 7:59 PM ET
On April 4, 2023, Anthony P. Bihl III was appointed as Interim Chief Executive Officer of the Company and as a Class III director of the Company, effective April 5, 2023.
Appointed

Anthony P. Bihl III

Class III director
BVS · Bioventus Inc.
Effective
2023-04-05
Filed
April 5, 2023, 7:59 PM ET
On April 4, 2023, Anthony P. Bihl III was appointed as Interim Chief Executive Officer of the Company and as a Class III director of the Company, effective April 5, 2023.
Departed

Kenneth Reali

director
BVS · Bioventus Inc.
Effective
2023-04-04
Successor
Anthony P. Bihl III
Filed
April 5, 2023, 7:59 PM ET
On April 3, 2023, the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”) informed Kenneth Reali that it had determined that he would transition from his role as Chief Executive Officer of the Company and, on April 4, 2023, Mr. Reali resigned as a director and officer of the Company.
Departed (interim)

Kenneth Reali

Chief Executive Officer
BVS · Bioventus Inc.
Effective
2023-04-04
Successor
Anthony P. Bihl III
Filed
April 5, 2023, 7:59 PM ET
On April 3, 2023, the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”) informed Kenneth Reali that it had determined that he would transition from his role as Chief Executive Officer of the Company and, on April 4, 2023, Mr. Reali resigned as a director and officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anthony P. Bihl III was appointed as Interim Chief Executive Officer at Bioventus Inc..

Action
appointed
Role
Interim Chief Executive Officer
Exact text from the filing
On April 4, 2023, Anthony P. Bihl III was appointed as Interim Chief Executive Officer of the Company and as a Class III director of the Company, effective April 5, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Anthony P. Bihl III was appointed as Class III director at Bioventus Inc..

Action
appointed
Role
Class III director
Exact text from the filing
On April 4, 2023, Anthony P. Bihl III was appointed as Interim Chief Executive Officer of the Company and as a Class III director of the Company, effective April 5, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kenneth Reali resigned as director at Bioventus Inc..

Action
resigned
Role
director
Exact text from the filing
On April 3, 2023, the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”) informed Kenneth Reali that it had determined that he would transition from his role as Chief Executive Officer of the Company and, on April 4, 2023, Mr. Reali resigned as a director and officer of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kenneth Reali resigned as Chief Executive Officer at Bioventus Inc..

Action
resigned
Role
Chief Executive Officer
Exact text from the filing
On April 3, 2023, the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”) informed Kenneth Reali that it had determined that he would transition from his role as Chief Executive Officer of the Company and, on April 4, 2023, Mr. Reali resigned as a director and officer of the Company.
View on SEC.gov

Bioventus Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-091610
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.